Ammonium lactate and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Ammonium lactate (ammonium lactate), especially for people who are male, 60+ old, also take Amlodipine, and have Mantle cell lymphoma.

The phase IV clinical study analyzes which people have Nosebleed when taking Ammonium lactate. It is created by eHealthMe based on reports of 2,138 people who have side effects when taking Ammonium lactate from the FDA, and is updated regularly.

What is Ammonium lactate?

Ammonium lactate has active ingredients of ammonium lactate. eHealthMe is studying from 2,151 Ammonium lactate users. Check the latest studies of Ammonium lactate.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,081 drugs and 3,091 conditions by eHealthMe. Check the latest studies of Nosebleed.

On Jul, 09, 2026

2,138 people reported to have side effects when taking Ammonium lactate.
Among them, 17 people (0.8%) have Nosebleed.

Among these 17 people:

What is the gender of people who have Nosebleed when taking Ammonium lactate? *

female: 37.5 %
male: 62.5 %

What is the age of people who have Nosebleed when taking Ammonium lactate? *

What are other drugs people take besides Ammonium lactate? *

What are other side effects people have besides Nosebleed? *

Fatigue (feeling of tiredness): 10 people, 58.82%
Thrombocytopenia (decrease of platelets in blood): 10 people, 58.82%
Weakness: 9 people, 52.94%
Weight Decreased: 8 people, 47.06%
Oedema Peripheral (superficial swelling): 8 people, 47.06%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 41.18%
Tremor (trembling or shaking movements in one or more parts of your body): 7 people, 41.18%
Pneumonia: 6 people, 35.29%
Dyspnea (difficult or laboured breathing): 6 people, 35.29%
Pulmonary Embolism (blockage of the main artery of the lung): 6 people, 35.29%

What are the existing conditions these people have? *

Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 6 people, 35.29%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 6 people, 35.29%
High Blood Pressure: 3 people, 17.65%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 17.65%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 17.65%
Pain: 3 people, 17.65%
Diarrhea: 2 people, 11.76%
Prostate Cancer: 2 people, 11.76%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 11.76%
Neuropathy Peripheral (surface nerve damage): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Ammonium lactate and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ammonium lactate:

Ammonium lactate (2,151 reports)

Nosebleed treatments and more:

Nosebleed (92,075 reports)

Browse all side effects of Ammonium lactate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Nosebleed (2,081 drugs)

Browse all the conditions that are associated with Nosebleed:

Nosebleed (3,091 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ammonium lactate (the active ingredients of Ammonium lactate) and Ammonium lactate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.